Kelly Leanne
SEC insider (Form 3/4/5 filer). CIK 0001398278. Chief Financial Officer at GRI Bio, Inc. (GRI) and 1 other issuer. 3 reported Form 4/5 transactions since Sep 2024; latest on Sep 18, 2025. Located in LA JOLLA, CA.
Companies Kelly Leanne has filed insider reports for
- GRI Bio, Inc. (GRI): Officer, Chief Financial Officer
- WINDTREE THERAPEUTICS INC /DE/ (WINT): Director
Kelly Leanne
CIK: 0001398278
Transaction Breakdown
Open Market Buys (P)0 (0.0%)
High conviction signal
Open Market Sales (S)0 (0.0%)
Position reduction
Option Exercises (M)0 (0.0%)
Derivative conversions
Awards (A)3 (100.0%)
Compensation grants
Other (G, F, J, C, D, …)0 (0.0%)
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Discretionary Trading P&L
Holdings
Transaction History (3 total)
- Sep 18, 2025GRI
GRI Bio, Inc.
AwardDirectStock Option (Right to Buy)
43.2K shares- - Aug 26, 2025GRI
GRI Bio, Inc.
AwardDirectStock Option (Right to Buy)
11.9K shares- - Jan 23, 2025GRI
GRI Bio, Inc.
AwardDirectStock Option (Right to Buy)
43.3K shares at avg. $0.69-
1-3 of 3 transactions